Coronary Artery Disease Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
University of California, San Francisco Fresno Center for Medical Education and Research, Fresno, CA, USA
Department of Cardiology, Mount Sinai School of Medicine, New York, NY, USA
Medical Center, Department of Cardiovascular Medicine, Duke University, Durham, NC, USA
Department of Internal Medicine IV, University of Frankfurt, Frankfurt, Germany
- » Cholesterol
- » Diabetes
- » Hypertension
- » Intervention
- » Percutaneous coronary intervention
- » Preventive cardiology
- » Primary surgery
- » Risk factors
- » Stable coronary disease
- » Unstable coronary disease
The major randomized controlled trials aimed at reducing cardiovascular disease events or mortality in patients with end-stage renal disease have been largely unsuccessful in reducing primary outcomes of cardiovascular disease events and/or mortality...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
5 Recommendations, most recent by| Controversial | Negative / Null Results | New Finding | Refutation
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.